| 注册
首页|期刊导航|临床神经病学杂志|静脉滴注联合鞘内/脑室内注射多粘菌素治疗颅内多重耐药菌感染有效性和安全性的Meta分析

静脉滴注联合鞘内/脑室内注射多粘菌素治疗颅内多重耐药菌感染有效性和安全性的Meta分析

周益毅 龙勇 谢尊椿 王联群 洪道俊

临床神经病学杂志2024,Vol.37Issue(1):15-19,5.
临床神经病学杂志2024,Vol.37Issue(1):15-19,5.

静脉滴注联合鞘内/脑室内注射多粘菌素治疗颅内多重耐药菌感染有效性和安全性的Meta分析

Meta-analysis of efficacy and safety of intravenous combined with intrathecal/intraventricular injection of polymyxin against intracranial infection with multidrug-resistant bacteria

周益毅 1龙勇 1谢尊椿 1王联群 1洪道俊1

作者信息

  • 1. 330006 南昌大学江西医学院第一附属医院神经内科
  • 折叠

摘要

Abstract

Objective Evaluation of the efficacy and safety of intravenous(IV)combined with intrathecal/intraventricular injection(ITH/IVT)of polymyxin against intracranial infection with multidrug-resistant bacteria.Methods The databases,including Wanfang,VIP,Chinese Biomedical Literature,Pubmed,Embase,ScienceDirect,and Cochrane Library were searched,case-control studies on IV+ITH/IVT polymyxin against intracranial infection with multidrug-resistant bacteria by January 2023 were screen.RevMan 5.4 software was used for meta-analysis.Results A total of 9 retrospective studies were included.The fatality rate in IV+ITH/IVT polymyxin group was significantly lower than that in IV group(OR =0.19,95%CI:0.11-0.35,P<0.01).There was no significant difference in ICU hospitalization days(OR =-2.32,95%CI:-23.59-18.89,P =0.83)and adverse reaction rate(OR =0.93,95%CI:0.26-3.38,P =0.91)between IV+ITH/IVT group and IV group.Conclusion IV+ITH/IVT polymyxin in treating the intracranial infection with multidrug-resistant bacteria can significantly reduce fatality rate,and does not significantly increase adverse reactions.

关键词

多粘菌素/颅内感染/鞘内注射/脑室内注射/Meta分析

Key words

polymyxin/encephalitis/intrathecal injection/intraventricular injection/Meta analysis

分类

医药卫生

引用本文复制引用

周益毅,龙勇,谢尊椿,王联群,洪道俊..静脉滴注联合鞘内/脑室内注射多粘菌素治疗颅内多重耐药菌感染有效性和安全性的Meta分析[J].临床神经病学杂志,2024,37(1):15-19,5.

临床神经病学杂志

OACSTPCD

1004-1648

访问量0
|
下载量0
段落导航相关论文